ClinicalTrials.gg
Status unknownNCT04052321CHESTUpdated Nov 4, 2020

Quantification of Chest Wall Changes After Nuss Bar Removal Utilizing Three-dimensional Optical Surface Scans

An interventional study of 3D optical surface scan in Pectus Excavatum, sponsored by Zuyderland Medisch Centrum. Status unknown at 1 site in Netherlands. Per ClinicalTrials.gov, last updated 2020-11-04.

Sponsored by Zuyderland Medisch Centrum · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Jul 2020), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Sex
All
01

Study summary

Pectus excavatum is the most common anterior chest wall deformity that affects up to 1:400 of newborns. If an operative correction is indicated, patients are often operated via the Ravitsch or Nuss bar procedure. The latter (i.e. the Nuss bar procedure) is the most commonly performed procedure. During this procedure one or more metal bars are inserted behind the sternum to push the sternum back into its normal position. These bars remain in situ for two-to-three years before being removed. Despite the fact that the Nuss bar procedure is regarded as an effective procedure, retraction may occur after removal. A recent study has investigated this phenomenon, utilizing three-dimensional (3D) optical surface scans acquired before and after Nuss bar removal. The authors found statistically significant changes to occur in chest wall dimensions directly after, as well as between 2 and 8 weeks after Nuss bar explantation, in comparison to the situation just prior to bar removal. They, moreover, found the time the bar was in situ to be predictive for retraction. However, the authors also stressed that further studies are needed to reinforce their preliminary findings and perform long-term assessments. Subsequently, a similar study with long-term assessments will be conducted.

02

Conditions studied

  • Pectus Excavatum

Browse trials for

Keywords

  • Three-dimensional optical surface imaging
  • Chest wall changes
03

In context

Funnel Chest

79 studies on the registry are indexed under Funnel Chest; 10 are open to participants now.

This study's planned enrollment of 25 is below the median of 40 across 46 interventional studies indexed under Funnel Chest.

Browse Funnel Chest studies →

Lead sponsor

Zuyderland Medisch Centrum is the lead sponsor of 64 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients that received 1 or more Nuss bar(s) to treat pectus excavatum and is/are scheduled to be removed due to the end of treatment.

Exclusion criteria

Exclusion Criteria:

  • Patients in which the Nuss bar(s) or its stabilizers are or have been dislocated.
  • Patients that received a second operation to treat any complications regarding the initial Nuss bar implantation.
  • Patients with proven connective tissue diseases (e.g. Marfan's syndrome).
  • Patients with a diagnosis of epilepsy (as the 3D scanner utilizes flashing light to acquire the torso topography)
  • Patients that are not fit to remain in a standing position with their arms above shoulder level for a maximum of 60 seconds.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (estimated)

Study arms

  • Experimental
    3D scan arm

    This is a single arm study. Patients in this arm will receive a 3D scan just prior to, 2 weeks after, as well as 6 and 12 months after Nuss bar removal.

    Other: 3D optical surface scan

Interventions

  • Other3D optical surface scan

    A 3D optical surface scan is acquired utilizing a handheld 3D scanner. Such a scanner is comparable to an ordinary photo camera, however, it also records depth.

06

What researchers measure

Primary outcomes

  1. Mean change in distance

    The mean distance of thoracic wall changes

    Time frame: Changes from baseline (prior to surgery) to the situation 2 weeks after surgery, as well as after 6 and 12 months

  2. Maximum change in distance

    The maximum distance of thoracic wall changes

    Time frame: Changes from baseline (prior to surgery) to the situation 2 weeks after surgery, as well as after 6 and 12 months

  3. Volumetric changes

    The volumetric chest wall changes

    Time frame: Changes from baseline (prior to surgery) to the situation 2 weeks after surgery, as well as after 6 and 12 months

Secondary outcomes

  1. Predictors of chest wall changes

    Predictors of chest wall changes, assessed by multivariate analysis.

    Time frame: Changes in volume, mean and maximum distance from baseline to 12 months

07

Study locations

1 site
  • Zuyderland Medical Centre
    Heerlen, Limburg 6419PC, Netherlands
08

References and documents

Publications

  • Gomes-Fonseca J, Vilaca JL, Henriques-Coelho T, Direito-Santos B, Pinho ACM, Fonseca JC, Correia-Pinto J. A new methodology for assessment of pectus excavatum correction after bar removal in Nuss procedure: Preliminary study. J Pediatr Surg. 2017 Jul;52(7):1089-1097. doi: 10.1016/j.jpedsurg.2016.12.029. Epub 2017 Jan 7. PubMed 28094014 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 4, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04052321
Lead sponsor
Zuyderland Medisch Centrum
Responsible party
Sponsor
First posted
Aug 9, 2019
Start date
Jan 2021 (estimated)
Primary completion
Jan 2022 (estimated)
Completion
Jan 2022 (estimated)
Last update
Nov 4, 2020

Study contacts

Jean Daemen
Contact
j.daemen@zuyderland.nl
+31884597777

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion